The 1st HoneyNaps Sleep & Tech Symposium Presentation of the 'SLEEP 2024 White Paper' and the Latest Advances in Sleep Research & Technology Unveiling of HoneyNaps' New Brand Identity BOSTON , Aug. 27, 2024 /PRNewswire/ -- HoneyNaps USA , Inc., an AI-driven sleep data analysis company, proudly hosted the "1st HoneyNaps Sleep & Tech Symposium" on August 10th at Maple Hall, Grand InterContinental Seoul Parnas.
As HoneyNaps approaches its 10th anniversary next year, it continues to lead the sleep tech industry as the first company in Korea and Asia to receive U.S. FDA approval for its "SOMNUM" sleep disorder diagnostic software.
HoneyNaps has established itself as a pioneer in the field, offering comprehensive technology for sensing bio-signals during sleep, along with advanced analysis, diagnosis, and therapeutic solutions. The symposium brought together experts from various disciplines, including psychiatry, otolaryngology, cardiology, and neurology, to discuss cutting-edge research trends. Presentations covered topics such as the glymphatic system and brain health, the connection between cardiovascular health and sleep, and global trends in sleep research and technology, including the latest developments in digital cognitive behavioral therapy for insomnia (dCBT-i).
The symposium also shared key insights from the "SLEEP 2024" publication, which reflects the latest trends from the American Academy of Sleep Medicine. HoneyNaps has contributed to this publication for three conse.